期刊文献+

法舒地尔对压力超负荷大鼠心脏的肌成纤维细胞表型分化的影响 被引量:2

Impact of Fasudil on cardiac myofibroblast differentiation in pressure overload rats
下载PDF
导出
摘要 目的 Rho激酶介导的肌动蛋白细胞骨架重组在肌成纤维细胞(MFB)表型分化中具有重要作用。本实验拟观察Rho激酶抑制剂法舒地尔对压力超负荷大鼠心脏MFB表型分化的影响。方法采用腹主动脉缩窄法建立压力超负荷诱导的心肌纤维化大鼠模型。假手术组(Sham组)仅分离但不予结扎腹主动脉。术后4周末,将存活大鼠按随机数表法分为模型组(Model组)、法舒地尔高剂量组(FH组)和法舒地尔低剂量组(FL组)。药物干预4周末,观察大鼠心肌病理学改变,并检测心肌羟脯氨酸(HYP)含量,评估心肌纤维化程度;酶联免疫吸附法检测血浆和心肌血管紧张素Ⅱ(AngⅡ)含量;免疫组织化学法分析心肌磷酸化肌球蛋白磷酸酶靶蛋白亚基1(p-MYPT1)、α-平滑肌肌动蛋白(α-SMA)、骨桥蛋白(OPN)和转化生长因子β1(TGF-β1)的表达。结果 Model组大鼠心肌纤维化程度较Sham组明显加重,AngⅡ含量显著升高,p-MYPT1(0.063±0.009比0.029±0.014)、α-SMA(0.034±0.009比0.004±0.003)、OPN(0.043±0.007比0.012±0.006)和TGF-β1(0.058±0.019比0.019±0.009)的表达均明显升高(均为P<0.01);FH组和FL组大鼠心肌纤维化程度较Model组减轻,AngⅡ含量均显著下降,p-MYPT1(0.029±0.013和0.040±0.011)、α-SMA(0.016±0.006和0.027±0.007)、OPN(0.018±0.004和0.036±0.006)和TGF-β1(0.022±0.013和0.039±0.014)的表达也不同程度下降(P<0.01或P<0.05)。结论法舒地尔改善压力超负荷大鼠心肌纤维化的作用至少与部分抑制MFB表型分化有关。 Objective Rho kinase mediated cytoskeleton actin reorganization plays an important role in the phenotypic differentiation of myofibroblasts. The study is to investigate the effects of Fasudil- a Rho kinase inhibitor on myofibroblasts differentiation in pressure overload rats. Methods Pressure overload induced myocardial fibrosis rats models were established by abdominal aortic constriction. In sham group the abdominal aorta was just separated but not ligated. The 4 weeks after surgery, the operation survival rats were randomly divided into 3 groups : control model group, Fasudil high dose group ( FH group) and Fasudil low dose group ( FL group). And 4 weeks after the drug intervention, the degree of myocardial fibrosis was assessed as follows: pathologic changes were observed and hydroxyproline contents of the myocardium were determined; the content of angiotensin Ⅱ (Ang-Ⅱ ) was calculated by enzyme linked immunosorbent assay (Elisa) ; the expression levels of phosphorylated myosin phosphatase target subunit 1 (p-MYPT1), a-smooth muscle actin (α-SMA), osteopontin (OPN) and transforming growth factor-β1 ( TGF-β1 ) were analyzed by immunohistochemistry. Results Compared with the sham group, the degree of myocardial fibrosis in model group was aggravated variously, and the content of Ang- Ⅱ and the expression levels of p-MYPT1 (0.063 ±0.009 vs. 0.029±0.014), α-SMA (0.034±0.009 vs. 0.004±0.003), OPN (0.043 ±0.007 vs. 0.012 ±0.006) and TGF-β1 (0.058 ±0.019 vs. 0.019±0.009) were significantly increased ( all P 〈 0. 01 ). Compared with the model group, the degree of myocardial fibrosis in FH group and FL group were relieved, and the content of Ang- Ⅱ and the expression levels of p-MYPT1 (0.029±0.013, 0.040±0.011), ot-SMA (0.016 ±0.006, 0.027 ± 0.007), OPN (0.018 ±0.004, 0. 036 ± 0. 006) and TGF-β1 (0. 022 ± 0. 013, 0. 039 ± 0. 014) were significantly decreased ( P 〈 0.05 or P 〈 0.01 ). Conclusions The protection effect of Fasudil on myocardial fibrosis in pressure overloaded rats is at least partially related to the inhibition of myofibroblast differentiation.
出处 《中国心血管杂志》 2015年第4期284-289,共6页 Chinese Journal of Cardiovascular Medicine
基金 南京军区南京总医院科研基金项目(2014016)~~
关键词 肌成纤维细胞 法舒地尔 压力超负荷 心肌纤维化 Myofibroblast Fasudil Pressure overload Myocardial fibrosis
  • 相关文献

参考文献14

  • 1Weber KT,Sun Y,Bhattacharya SK,et al.Myofibroblastmediated mechanisms of pathological remodelling of the heart[J].Nat Rev Cardiol,2013,10:15-26.
  • 2Huang X,Yang N,Fiore VF,et al.Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction[J].Am J Respir Cell Mol Biol,2012,47:340-348.
  • 3Manickam N,Patel M,Griendling KK,et al.Rho A/Rho kinase mediates TGF-beta1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species[J].Am J Physiol Renal Physiol,2014,307:F159-171.
  • 4Yang R,Chang L,Liu S,et al.High glucose induces Rho/ROCK-dependent visfatin and type I procollagen expression in rat primary cardiac fibroblasts[J].Mol Med Rep,2014,10:1992-1998.
  • 5蔡辉,张培勇,董晓蕾,赵凌杰,赵智明.Rho激酶抑制剂对压力超负荷大鼠血管紧张素(1-7)的影响[J].医学研究生学报,2013,26(11):1142-1146. 被引量:3
  • 6Anversa P,Olivetti G,Melissari M,et al.Morphometric study of myocardial hypertrophy induced by abdominal stensis[J].Lab Invest,1979,40:341-349.
  • 7Street CA,Bryan BA.Rho kinase proteins——pleiotropic modulators of cell survival and apoptosis[J].Anticancer Res,2011,31:3645-3657.
  • 8Shimokawa H,Takeshita A.Development of rho-kinase inhibitors for cardiovascular medicine[J].Trends Pharmacol Sci,2007,28:296-302.
  • 9Porter KE,Turner NA,O'Regan DJ,et al.Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of rhoa[J].Cardiovasc Res,2004,61:745-755.
  • 10Aikawa E,Whittaker P,Farber M,et al.Human semilunar cardiac valve remodeling by activated cells from fetus to adult:implications for postnatal adaptation,pathology,and tissue engineering[J].Circulation,2006,113:1344-1352.

二级参考文献20

  • 1Gomes ER, Santos RA, Guatimosim S. Angiotensin-( 1-7 ) -medi- ated signaling in cardiomyocytes [ J ]. lnt J Hypertens, 2012, 2012 : 493129.
  • 2Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity[J]. Cytoskel- eton (Hoboken), 2010, 67(9): 545-554.
  • 3Satoh K, Fukumoto Y, Shimokawa H. Rho-kinase: important new therapeutic target in cardiovascular diseases [ J ]. Am J Physiol Heart Circ Physiol, 2011, 301(2) : H287-H296.
  • 4Li Q, Xu Y, Li X, et al. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myo- cardial infarction : role of TGF-betal-TAKI [ J ]. Toxicol Lett, 2012, 211(2): 91-97.
  • 5Anversa P, Olivetti G, Melissari M, et al. Morphometric study of myocardial hypertrophy induced by abdominal aortic stenosis[ J]. Lab Invest, 1979, 40(3) : 341-349.
  • 6Satoh S, Hitomi A, Ikegaki I, et al. Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotec- tive effects of Rho-kinase inhibitors against ischemic brain damage [J]. Brain Res Bull, 2010, 81(1) : 191-195.
  • 7McCollum LT, Gallagher PE, Ann Tallant E. Angiotensin-( 1-7 ) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1 [ J ]. Am J Physiol Heart Circ Physiol, 2012, 302 (3) : H801-H810.
  • 8Sun Y. Intracardiac renin-angiotensin system and myocardial re- pair/remodeling following infarction [ J ]. J Mol Cell Cardiol, 2010, 48(3): 483-489.
  • 9Kumar R, Singh VP, Baker KM. The intracellular renin-angioten- sin system : implications in cardiovascular remodeling [ J ]. Curr Opin Nephrol Hypertens, 2008, 17(2) : 168-173.
  • 10Ferreira A J, Shenoy V, Qi Y, et al. Angiotensin-converting en- zyme 2 activation protects against hypertension-induced cardiac fi- brosis involving extracellular signal-regulated kinases [ J ]. Exp Physiol, 2011, 96(3): 287-294.

共引文献2

同被引文献12

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部